MIRMMirum Pharmaceuticals, Inc.
96.31USD-5.80%Mkt Cap: 5.87B $P/E: —3d ago
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap5.87B $
Enterprise Value6.63B $
Revenue (TTM)618.07M $
Gross Profit421.07M $
Net Income (TTM)-23.36M $
Revenue/Share11.02 USD
Last Price96.31 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees433
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS6047491013
Valuation
P/E (Trailing)—
P/E (Forward)-280.01
PEG—
EV/EBITDA-94.30
EV/Revenue10.72
P/S9.58
P/B-602.92
EPS (TTM)-13.38
EPS (Forward)-0.35
52W Range
63.2350% of range130.00
52W High130.00 USD
52W Low63.23 USD
Profitability
Gross Margin80.77%
Oper. Margin-14.81%
EBITDA Margin-11.37%
Profit Margin-4.48%
ROE-7.42%
ROA-2.77%
Growth
Revenue Growth37.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF55.83M $
CapEx (TTM)954.00K $
FCF Margin12.40%
FCF Yield1.30%
Net Debt324.66M $
Net Debt/EBITDA-4.62
Balance Sheet
Debt/Equity1.02
Current Ratio2.86
Quick Ratio2.62
Book Value/Sh-0.1610 USD
Cash/Share6.750 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)138.21 USD
Upside (mean)+43.5%
Target Range118.00 USD – 183.00 USD
$118.00+43.5% to mean$183.00
# Analysts14
Ownership
Shares Out.60.98M
Float56.42M
Insiders1.29%
Institutions111.94%
Short Interest
Short Ratio10.5d
Short % Float14.68%
Short % Out.11.19%
Shares Short6.82M
Short (prev mo.)7.48M
Technical
SMA 50110.48 (-12.8%)
SMA 20094.50 (+1.9%)
Beta0.51
S&P 52W Chg18.16%
Avg Vol (30d)659.56K
Avg Vol (10d)602.05K
Technical Indicators
RSI (14)37.9
MACD-3.7953
MACD Signal-3.4384
MACD Hist.-0.3570
BB Upper116.87 USD
BB Middle104.15 USD
BB Lower91.44 USD
BB Width24.42%
ATR (14)4.977 USD
Vol Ratio (20d)0.93x